Scinovex
article Open Access

The comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to bupivacaine

International Journal of Advanced Research in Medicine · 2022 · Vol. 4(1) · pp. 152–155
Suresh K. BhargavaNeena Tiwari

Abstract

Introduction: Spinal anaesthesia provided by bupivacaine may be to short for providing postoperative analgesia. This study is conducted for the understating and calculation of the efficacy of intrathecal fentanyl and intrathecal dexmedetomidine as an adjuvant to hyperbaric bupivacaine with regards to the onset duration of sensory and motor blockade. Material & Method: 200 patients were taken with difference age group and classified into two groups. Both group consist 100 patients and given spinal anaesthesia using bupivacaine 0.5%, heavy 2.5 ml with either fentanyl 25µg (group A) or 5µg of preservative free dexmedetomidine (group B). Result: During sedation we take proper measurement of major vital organ such as taken pulse rate, respiratory rate, blood pressure, and arterial oxygen saturation were obtained. After operation patient analgesia time were recorded.

Anesthesia and Sedative AgentsAnesthesia and Pain ManagementAnesthesia and Neurotoxicity ResearchDexmedetomidineBupivacaineMedicineAnesthesiaFentanylSedationAdjuvantBlood pressureIntrathecalHeart rate
Citations
2
FWCI
0.25
field-weighted impact
References
6
Percentile
55%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to bupivacaine · Scinovex